CinCor Pharma Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
19
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.76B
- Investors
-
2
CinCor Pharma General Information
Description
Developer of cardiovascular, metabolic, and kidney disease drugs designed to advance promising clinical candidates toward marketing approval. The company is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.
Contact Information
Website
www.cincor.comCorporate Office
- 230 Third Avenue
- 6th Floor
- Waltham, MA 02451
- United States
Corporate Office
- 230 Third Avenue
- 6th Floor
- Waltham, MA 02451
- United States
CinCor Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 24-Feb-2023 | $1.76B | Completed | Generating Revenue | ||
| 4. 2PO | 12-Aug-2022 | Completed | Generating Revenue | |||
| 3. IPO | 07-Jan-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 22-Sep-2021 | $143M | $193M | Completed | Clinical Trials - Phase 2 | |
| 1. Early Stage VC (Series A) | 14-May-2019 | $50M | $50M | Completed | Clinical Trials - Phase 2 |
CinCor Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
CinCor Pharma Comparisons
Industry
Financing
Details
CinCor Pharma Competitors (67)
One of CinCor Pharma’s 67 competitors is Aclaris Therapeutics, a Formerly VC-backed company based in Wayne, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA | ||||
| Rein Therapeutics | Formerly VC-backed | Austin, TX | ||||
| Zealand Pharma | Formerly VC-backed | Soborg, Denmark | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA |
CinCor Pharma Patents
CinCor Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023320092-A1 | Method of treating hypertension with the aldosterone synthase inhibitor baxdrostat | Pending | 05-Aug-2022 | ||
| EP-4565235-A1 | Method of treating hypertension with the aldosterone synthase inhibitor baxdrostat | Active | 05-Aug-2022 | ||
| US-20260041679-A1 | Method of treating hypertension with the aldosterone synthase inhibitor baxdrostat | Pending | 05-Aug-2022 | ||
| WO-2024030615-A1 | Method of treating hypertension with the aldosterone synthase inhibitor baxdrostat | Inactive | 05-Aug-2022 | ||
| JP-2025525936-A | Methods for treating hypertension with the aldosterone synthase inhibitor baxdrostat | Pending | 05-Aug-2022 | A61K31/4725 |
CinCor Pharma Signals
CinCor Pharma Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 5AM Ventures | Venture Capital | Minority | ||
| Adage Capital Management | Hedge Fund | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| General Atlantic | Growth/Expansion | Minority | ||
| LAV (Lilly Asia Fund) | Corporate Venture Capital | Minority |
CinCor Pharma ESG
Risk Overview
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
CinCor Pharma FAQs
-
When was CinCor Pharma founded?
CinCor Pharma was founded in 2018.
-
Where is CinCor Pharma headquartered?
CinCor Pharma is headquartered in Waltham, MA.
-
What is the size of CinCor Pharma?
CinCor Pharma has 19 total employees.
-
What industry is CinCor Pharma in?
CinCor Pharma’s primary industry is Drug Discovery.
-
Is CinCor Pharma a private or public company?
CinCor Pharma is a Private company.
-
What is the current valuation of CinCor Pharma?
The current valuation of CinCor Pharma is .
-
What is CinCor Pharma’s current revenue?
The current revenue for CinCor Pharma is .
-
How much funding has CinCor Pharma raised over time?
CinCor Pharma has raised $533M.
-
Who are CinCor Pharma’s investors?
5AM Ventures, Adage Capital Management, BVF Partners, General Atlantic, and LAV (Lilly Asia Fund) are 5 of 13 investors who have invested in CinCor Pharma.
-
Who are CinCor Pharma’s competitors?
Aclaris Therapeutics, Rein Therapeutics, Zealand Pharma, Sarepta Therapeutics, and Sorrento Therapeutics are some of the 67 competitors of CinCor Pharma.
-
When was CinCor Pharma acquired?
CinCor Pharma was acquired on 24-Feb-2023.
-
Who acquired CinCor Pharma?
CinCor Pharma was acquired by AstraZeneca.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process